Nexavar

Action on Nexavar does not violate any treaty, says Anand Sharma

New Delhi, June 9: India, on Friday, said it had not violated any multi-lateral trade agreement by issuing compulsory licence for patented anti-cancer drug — Nexavar — to be produced and sold at a much